Industry: Chemical & Material
Published Date: 2025-01-16
Pages: 110 Pages
Report ld: 3562966
Request Sample
Customized Report
D-Amphetamine Sulfate API Market Size(US$)

CAGR 2025-2031
4.8%
Market Size,2031
USD 80.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
D-Amphetamine Sulfate API is a crucial raw material for neuroregulatory drugs, widely used in the treatment of neurological and psychiatric disorders like Attention Deficit Hyperactivity Disorder (ADHD). As the focus on neural health continues to grow, the market demand is steadily increasing. The market size is expanding, with consistent growth in sales. Furthermore, the specific uses of D-Amphetamine Sulfate are diversifying, including its illicit misuse in the realm of sports and athletics. In the future, with advancements in technology and healthcare, the D-Amphetamine Sulfate API is poised to play a more significant role in the treatment of a broader range of neurological and psychiatric disorders.
This report aims to provide a comprehensive presentation of the global market for D-Amphetamine Sulfate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of D-Amphetamine Sulfate API by region & country, by Type, and by Application.
The D-Amphetamine Sulfate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding D-Amphetamine Sulfate API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of D-Amphetamine Sulfate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of D-Amphetamine Sulfate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of D-Amphetamine Sulfate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 D-Amphetamine Sulfate API Product Introduction
1.2 Global D-Amphetamine Sulfate API Market Size Forecast
1.2.1 Global D-Amphetamine Sulfate API Sales Value (2020-2031)
1.2.2 Global D-Amphetamine Sulfate API Sales Volume (2020-2031)
1.2.3 Global D-Amphetamine Sulfate API Sales Price (2020-2031)
1.3 D-Amphetamine Sulfate API Market Trends & Drivers
1.3.1 D-Amphetamine Sulfate API Industry Trends
1.3.2 D-Amphetamine Sulfate API Market Drivers & Opportunity
1.3.3 D-Amphetamine Sulfate API Market Challenges
1.3.4 D-Amphetamine Sulfate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global D-Amphetamine Sulfate API Players Revenue Ranking (2024)
2.2 Global D-Amphetamine Sulfate API Revenue by Company (2020-2025)
2.3 Global D-Amphetamine Sulfate API Players Sales Volume Ranking (2024)
2.4 Global D-Amphetamine Sulfate API Sales Volume by Company Players (2020-2025)
2.5 Global D-Amphetamine Sulfate API Average Price by Company (2020-2025)
2.6 Key Manufacturers D-Amphetamine Sulfate API Manufacturing Base and Headquarters
2.7 Key Manufacturers D-Amphetamine Sulfate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of D-Amphetamine Sulfate API
2.9 D-Amphetamine Sulfate API Market Competitive Analysis
2.9.1 D-Amphetamine Sulfate API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by D-Amphetamine Sulfate API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in D-Amphetamine Sulfate API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 USP
3.1.2 EP
3.2 Global D-Amphetamine Sulfate API Sales Value by Type
3.2.1 Global D-Amphetamine Sulfate API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global D-Amphetamine Sulfate API Sales Value, by Type (2020-2031)
3.2.3 Global D-Amphetamine Sulfate API Sales Value, by Type (%) (2020-2031)
3.3 Global D-Amphetamine Sulfate API Sales Volume by Type
3.3.1 Global D-Amphetamine Sulfate API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global D-Amphetamine Sulfate API Sales Volume, by Type (2020-2031)
3.3.3 Global D-Amphetamine Sulfate API Sales Volume, by Type (%) (2020-2031)
3.4 Global D-Amphetamine Sulfate API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Attention Deficit Hyperactivity Disorder
4.1.2 Narcolepsy
4.1.3 Other
4.2 Global D-Amphetamine Sulfate API Sales Value by Application
4.2.1 Global D-Amphetamine Sulfate API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global D-Amphetamine Sulfate API Sales Value, by Application (2020-2031)
4.2.3 Global D-Amphetamine Sulfate API Sales Value, by Application (%) (2020-2031)
4.3 Global D-Amphetamine Sulfate API Sales Volume by Application
4.3.1 Global D-Amphetamine Sulfate API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global D-Amphetamine Sulfate API Sales Volume, by Application (2020-2031)
4.3.3 Global D-Amphetamine Sulfate API Sales Volume, by Application (%) (2020-2031)
4.4 Global D-Amphetamine Sulfate API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global D-Amphetamine Sulfate API Sales Value by Region
5.1.1 Global D-Amphetamine Sulfate API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global D-Amphetamine Sulfate API Sales Value by Region (2020-2025)
5.1.3 Global D-Amphetamine Sulfate API Sales Value by Region (2026-2031)
5.1.4 Global D-Amphetamine Sulfate API Sales Value by Region (%), (2020-2031)
5.2 Global D-Amphetamine Sulfate API Sales Volume by Region
5.2.1 Global D-Amphetamine Sulfate API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global D-Amphetamine Sulfate API Sales Volume by Region (2020-2025)
5.2.3 Global D-Amphetamine Sulfate API Sales Volume by Region (2026-2031)
5.2.4 Global D-Amphetamine Sulfate API Sales Volume by Region (%), (2020-2031)
5.3 Global D-Amphetamine Sulfate API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America D-Amphetamine Sulfate API Sales Value, 2020-2031
5.4.2 North America D-Amphetamine Sulfate API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe D-Amphetamine Sulfate API Sales Value, 2020-2031
5.5.2 Europe D-Amphetamine Sulfate API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific D-Amphetamine Sulfate API Sales Value, 2020-2031
5.6.2 Asia Pacific D-Amphetamine Sulfate API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America D-Amphetamine Sulfate API Sales Value, 2020-2031
5.7.2 South America D-Amphetamine Sulfate API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa D-Amphetamine Sulfate API Sales Value, 2020-2031
5.8.2 Middle East & Africa D-Amphetamine Sulfate API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions D-Amphetamine Sulfate API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions D-Amphetamine Sulfate API Sales Value
6.2.1 Key Countries/Regions D-Amphetamine Sulfate API Sales Value, 2020-2031
6.2.2 Key Countries/Regions D-Amphetamine Sulfate API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States D-Amphetamine Sulfate API Sales Value, 2020-2031
6.3.2 United States D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe D-Amphetamine Sulfate API Sales Value, 2020-2031
6.4.2 Europe D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China D-Amphetamine Sulfate API Sales Value, 2020-2031
6.5.2 China D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.5.3 China D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan D-Amphetamine Sulfate API Sales Value, 2020-2031
6.6.2 Japan D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea D-Amphetamine Sulfate API Sales Value, 2020-2031
6.7.2 South Korea D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia D-Amphetamine Sulfate API Sales Value, 2020-2031
6.8.2 Southeast Asia D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India D-Amphetamine Sulfate API Sales Value, 2020-2031
6.9.2 India D-Amphetamine Sulfate API Sales Value by Type (%), 2024 VS 2031
6.9.3 India D-Amphetamine Sulfate API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Veranova
7.1.1 Veranova Company Information
7.1.2 Veranova Introduction and Business Overview
7.1.3 Veranova D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Veranova D-Amphetamine Sulfate API Product Offerings
7.1.5 Veranova Recent Development
7.2 Cambrex
7.2.1 Cambrex Company Information
7.2.2 Cambrex Introduction and Business Overview
7.2.3 Cambrex D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Cambrex D-Amphetamine Sulfate API Product Offerings
7.2.5 Cambrex Recent Development
7.3 Curia Global
7.3.1 Curia Global Company Information
7.3.2 Curia Global Introduction and Business Overview
7.3.3 Curia Global D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Curia Global D-Amphetamine Sulfate API Product Offerings
7.3.5 Curia Global Recent Development
7.4 Mallinckrodt Pharmaceuticals
7.4.1 Mallinckrodt Pharmaceuticals Company Information
7.4.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.4.3 Mallinckrodt Pharmaceuticals D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Mallinckrodt Pharmaceuticals D-Amphetamine Sulfate API Product Offerings
7.4.5 Mallinckrodt Pharmaceuticals Recent Development
7.5 Axyntis Group
7.5.1 Axyntis Group Company Information
7.5.2 Axyntis Group Introduction and Business Overview
7.5.3 Axyntis Group D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Axyntis Group D-Amphetamine Sulfate API Product Offerings
7.5.5 Axyntis Group Recent Development
7.6 Chattem Chemicals
7.6.1 Chattem Chemicals Company Information
7.6.2 Chattem Chemicals Introduction and Business Overview
7.6.3 Chattem Chemicals D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Chattem Chemicals D-Amphetamine Sulfate API Product Offerings
7.6.5 Chattem Chemicals Recent Development
7.7 Chr. Olesen
7.7.1 Chr. Olesen Company Information
7.7.2 Chr. Olesen Introduction and Business Overview
7.7.3 Chr. Olesen D-Amphetamine Sulfate API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Chr. Olesen D-Amphetamine Sulfate API Product Offerings
7.7.5 Chr. Olesen Recent Development
8 Industry Chain Analysis
8.1 D-Amphetamine Sulfate API Industrial Chain
8.2 D-Amphetamine Sulfate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 D-Amphetamine Sulfate API Sales Model
8.5.2 Sales Channel
8.5.3 D-Amphetamine Sulfate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 60.94 million in 2025 and is projected to reach US$ 84.23 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 129
USD 3950.00
(Single User License)
The global D-Amphetamine Sulfate API market was valued at US$ 60.94 million in 2025 and is anticipated to reach US$ 84.23 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 133
USD 2900.00
(Single User License)
The global D-Amphetamine Sulfate API market size was US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 79
USD 4250.00
(Single User License)
The global D-Amphetamine Sulfate API market is projected to grow from US$ 58.4 million in 2024 to US$ 80.7 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 140
USD 4900.00
(Single User License)
The global market for D-Amphetamine Sulfate API was valued at US$ 58.4 million in the year 2024 and is projected to reach a revised size of US$ 80.7 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-04-15
Pages: 92
USD 4900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-01-18
Pages: 94
USD 2900.00
(Single User License)
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published Date: 2024-01-15
Pages: 93
USD 3950.00
(Single User License)
The global market for D-Amphetamine Sulfate API was estimated to be worth US$ 60.94 million in 2025 and is projected to reach US$ 84.23 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 129
The global D-Amphetamine Sulfate API market was valued at US$ 60.94 million in 2025 and is anticipated to reach US$ 84.23 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-04-18
Pages: 133
The global D-Amphetamine Sulfate API market size was US$ 58.4 million in 2024 and is forecast to a readjusted size of US$ 80.7 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 79
The global D-Amphetamine Sulfate API market is projected to grow from US$ 58.4 million in 2024 to US$ 80.7 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 140
The global market for D-Amphetamine Sulfate API was valued at US$ 58.4 million in the year 2024 and is projected to reach a revised size of US$ 80.7 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-01-16
Pages: 86
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-04-15
Pages: 92
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-01-18
Pages: 94
D-Amphetamine Sulfate is a central nervous system (CNS) stimulant and an amphetamine enantiomer that is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by changing the amounts of certain natural substances in the brain.
Published: 2024-01-15
Pages: 93
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now